Natural killer cytotoxicity in the diagnosis of immune dysfunction: Criteria for a reproducible assay (original) (raw)
The Natural Killer Cell: A Historical Perspective and the Use of Supplements to Enhance NKC Activity
Pashupati Shah
Journal of Immune Based Therapies, Vaccines and Antimicrobials, 2012
View PDFchevron_right
Different subsets of natural killer T cells may vary in their roles in health and disease
Vipin Kumar
Immunology, 2014
View PDFchevron_right
Natural killer (NK) cells and their involvement in different types of cancer. Current status of clinical research
Isadora Zaharescu
Journal of Mind and Medical Sciences, 2017
View PDFchevron_right
Cytokine regulation of natural killer cell effector functions
Norberto Zwirner
BioFactors, 2010
View PDFchevron_right
Low level of FcγRIII expression on murine natural killer cells
Markus Biburger
Immunology Letters, 2012
View PDFchevron_right
Subtyping of natural killer cell cytotoxicity deficiencies in haemophagocytic lymphohistocytosis provides therapeutic guidance
Annacarin Horne, Gritta Janka
British Journal of Haematology, 2005
View PDFchevron_right
Clinical significance of natural killer cell cytotoxicity: Need for proper data analysis in the design of clinical studies
James Rusthoven
European Journal of Cancer and Clinical Oncology, 1985
View PDFchevron_right
Natural killer activity and lymphocyte subpopulations in patients with primary humoral and cellular immunodeficiencies
Massimo Fiorilli
Clinical Immunology and Immunopathology, 1981
View PDFchevron_right
Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors
Rafa Ramirez
European Journal of Immunology, 1990
View PDFchevron_right
Assessment of physiologic natural killer cell cytotoxicity in vitro
Thomas Binder
Human Immunology, 2011
View PDFchevron_right
Rapid flow cytometric assay for the assessment of natural killer cell activity
Douglas Chritton
Journal of Immunological Methods, 1993
View PDFchevron_right
Natural Killer Cell Dysfunction and Its Role in COVID-19
Jan Willem Cohen Tervaert
International Journal of Molecular Sciences, 2020
View PDFchevron_right
Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19
Jan Willem Cohen Tervaert
Blood Advances, 2020
View PDFchevron_right
Effects of in Vivo Treatment with FK506 on Natural Killer Cells in Rats
John Fung
Transplantation, 1991
View PDFchevron_right
Antigen phenotype and cytotoxic activity of natural killer cells in hemodialysis patients
Juana Ciudad
American Journal of Kidney Diseases, 1996
View PDFchevron_right
Evidence for a beta-adrenoceptor-mediated regulation of human natural killer cells
Kristoffer Hellstrand
Journal of Immunology, 1985
View PDFchevron_right
Enhanced natural killer activity and production of pro-inflammatory cytokines in mice selected for high acute inflammatory response (AIRmax
Lindsey Castoldi
View PDFchevron_right
Natural killer cell cytotoxic activity: measurement of the apoptotic inducing mechanisms
Sonya Marshall-Gradisnik
Clinical and Experimental Medical Sciences, 2013
View PDFchevron_right
In-vitro activation of natural killer cells from regional lymph nodes of melanoma patients with interleukin-2 and interleukin-15
Vladimir Jurisic
Melanoma Research, 2015
View PDFchevron_right
Natural killer cells: from “disturbing” background to central players of immune responses
Marianne Hokland
Molecular Immunology, 2005
View PDFchevron_right
Impaired natural killer activity in lymphohistiocytosis syndrome
Claude Griscelli
The Journal of Pediatrics, 1984
View PDFchevron_right
Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2
Eunice Wang
Journal of Clinical Investigation, 1993
View PDFchevron_right
The Cytotoxicity Pathway of Natural Killer Cells in Cord Blood Compared to P Eripheral Blood
Massoumeh Ebtekar
2004
View PDFchevron_right
Natural killer cells: a review of biology, therapeutic potential and challenges in treatment of solid tumors
Amanda Lenhard
Future Oncology, 2019
View PDFchevron_right
Determination of natural killer cell function by flow cytometry
John Schmitz
Clinical Diagnostic Laboratory Immunology, 1996
View PDFchevron_right
Human Natural Killer cells and other innate lymphoid cells in cancer: friends or foes?
Genny Del Zotto
Immunology Letters, 2018
View PDFchevron_right
Natural killer frequency determines natural killer cytotoxicity directly in accentuated zones and indirectly in “moderate-to-normal frequency” segment
Iryna Sudoma
Central European Journal of Immunology
View PDFchevron_right
of Allogeneic NK Cells Determinants of Antileukemia Effects
Paul Conn
2010
View PDFchevron_right
Natural killer activity of human blood lymphocytes
Maria Masucci
Molecular Immunology, 1982
View PDFchevron_right
In vivo enhancement of murine natural killer cell activity by 7-allyl-8-oxoguanosine (loxoribine)
Robert Capetola
International Journal of Immunopharmacology, 1992
View PDFchevron_right
Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications
Javier Hernandez
British Journal of Haematology, 1996
View PDFchevron_right
24. Clinical and laboratory assessment of immunity
John Schmitz
Journal of Allergy and Clinical Immunology, 2003
View PDFchevron_right
Antitumor Activity of NK Cells
Marianne Hokland
Immunologic Research, 2006
View PDFchevron_right
Killer cell immunoglobulin-like receptor 3DL1 licenses CD16-mediated effector functions of natural killer cells
Mark Connors
Journal of Leukocyte Biology, 2010
View PDFchevron_right
Natural Killer Cell Killing of Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Blasts by Killer Cell Immunoglobulin-Like Receptor–Negative Natural Killer Cells after NKG2A and LIR-1 Blockade
Robert Godal
Biology of Blood and Marrow Transplantation, 2010
View PDFchevron_right